Abstract: Novel compounds of general formula (1), which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
Type:
Grant
Filed:
February 9, 1999
Date of Patent:
September 5, 2000
Assignees:
SmithKline Beecham Corporation, Nycomed Austria GmbH
Inventors:
Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
Abstract: A pharmaceutical formulation comprising an amoxycillin hydrate and an effervescent couple, for example citric acid plus sodium bicarbonate or sodium glycine carbonate, or tartaric acid or malic acid plus sodium carbonate. Potassium equivalents of these sodium salts may be used. The formulations may be free flowing powders or granules, or tablets.
Type:
Grant
Filed:
October 24, 1994
Date of Patent:
September 29, 1998
Assignee:
Beecham Group plc
Inventors:
David Roy Merrifield, Paul Laurence Carter, David George Doughty
Abstract: Compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof and possessing antibacterial activity, and intermediates to compounds of formula I having the formula